CD44 and cancer: We included CEP-IL as additional control in the in vivo experiment to see the role of CD44 antibody intrinsically, as the stated antibody bound to an empty liposome is able to improve the therapeutic efficacy and inhibit tumor growth even without cancer drug [38].